Cleared Traditional

K863877 - BENZODIAZEPINE ENZYME IMMUNOASSAY KIT
(FDA 510(k) Clearance)

Mar 1987
Decision
157d
Days
Class 2
Risk

K863877 is an FDA 510(k) clearance for the BENZODIAZEPINE ENZYME IMMUNOASSAY KIT. This device is classified as a Enzyme Immunoassay, Benzodiazepine (Class II - Special Controls, product code JXM).

Submitted by General Diagnostics (Great Neck, US). The FDA issued a Cleared decision on March 12, 1987, 157 days after receiving the submission on October 6, 1986.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3170.

Submission Details

510(k) Number K863877 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 06, 1986
Decision Date March 12, 1987
Days to Decision 157 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code JXM — Enzyme Immunoassay, Benzodiazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3170

Similar Devices — JXM Enzyme Immunoassay, Benzodiazepine

All 89
Alinity c Benzodiazepines Reagent Kit
K243498 · Microgenics Corporation · Dec 2024
ONLINE DAT Benzodiazepines II
K221765 · Roche Diagnostics · Dec 2022
CEDIA Benzodiazepine Assay
K190968 · Microgenics Corporation · Dec 2019
DRI Benzodiazepine Assay
K173963 · Microgenics Corporation · Feb 2018
Psychemedics Microplate EIA for Benzodiazepines in Hair
K163590 · Psychemedics Corporation · Sep 2017
Healgen Multi-Drug Urine Test Cup; Healgen Multi-Drug Urine Test Dip Card
K163704 · Healgen Scientific, LLC · Aug 2017